chrisvoncsefalvay/vaers-outcomes huggingface dataset:
BLOOD CLOT IN LUNG; BLOOD CLOT IN CALF; This spontaneous report received from a patient concerned a 49 year old  male of unknown ethnic origin. The patient's weight, height, and medical history were not reported. The patient at the age of 48 years received covid-19 vaccine ad26.cov2.s (dose series 1) (suspension for injection, route of admin not reported, batch number: 206A21A, and expiry: 07-AUG-2021) dose was not reported, 1 total administered to left arm on 29-JUL-2021 for prophylactic vaccination. No concomitant medications were reported.  On 05-AUG-2021, a week after vaccination the patient could not breathe and had experienced blood clot in lung and calf, due to which the patient was going through hematologist and physician and was hospitalized for two nights. It was reported that hematologist and physician said that the patient was fine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from blood clot in lung, and blood clot in calf. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0:20211238393 -JANSSEN COVID-19 VACCINE Ad26.COV2.S -blood clot in lung, blood clot in calf. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Was visiting a friend. Ate dinner, had 2 drinks. Was standing around talking. Felt dizzy, walked to bedroom, asked if I could lie down, passed out cold on floor. From dizziness to collapse, about 2 minutes.
Reported tightening in throat, stridor, Fever of 100.3F, headache and myalgia. Symptoms managed with zantac, benadryl, tylenol and motrin
severe, uncontrolled shaking chills for 48 hours (to the point of not being able to hold a cup), severe diffuse myalgia that were incapacitating and required bedrest for 48 hours, severe pain at injection site with swelling from shoulder to elbow, redness, excruciating pain to touch for 72 hours, 10 + headache which recurred daily in form of severe migraines every day for 3 weeks, debilitating and requiring being supine and immobile most of the day, continued for 3 weeks, then complete laxity of hip joint, giving way, unable to walk. In all these have all resolved after a month and NONE of these were preexisting conditions or diagnoses, including no history of migraines or hip pain.  ( I am a PA and medical professional and have never experienced a reaction like this, nor have I ever had a patient in 40+ years have a reaction like this).  This WAS my first "senior" flu shot.
HAIR LOSS; This spontaneous report received from a patient concerned a 42 year old female.  The patient's height, and weight were not reported. The patient's concurrent conditions included: premenstrual dysphoric disorder (PMDD), temporomandibular joint (TMJ) disorder, penicillin (PCN) allergy, drug allergy (pseudoephedrine hydrochloride) ,and seasonal allergies.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 202A21A expiry: 21-SEP-2021) dose was not reported, 1 total administered on 28-APR-2021 to Left Arm for prophylactic vaccination. No concomitant medications were reported. (Dose series in number 1)  On 15-MAY-2021, following vaccination with covid-19 vaccine ad26.cov2.s the patient experienced hair loss. (Dose series in number 1)  The action taken with covid-19 vaccine ad26.cov2.s was not applicable.  The patient had not recovered from hair loss.  This report was non-serious.  This case, involving the same patient is linked to 20211115110.
When I tested positive the first time for COVID-19 I just had a scratchy throat. I went to the urgent care and was prescribed Paxlovid. Within in three days my symptoms were gone. Then I tested positive again on September 11th in the morning.  I went to the urgent care and they prescribed Paxlovid and again my symptoms lasted for 3 days. I had a lot sinus drain and nose blowing like a cold.
This spontaneous report was received from a registered nurse via medical assistant and refers to a 13-month-old female patient. The patient's pertinent medical history, concurrent conditions, concomitant medications, past drugs and drug allergies were not reported. On 08-SEP-2017, the patient was vaccinated with improperly stored VARIVAX (lot # M039317; expiry date: 20-SEP-2018) and M-M-R II (lot # M034387; expiry date: 19-JUL-2018) for prophylaxis. The dose of VARIVAX was reconstituted with properly stored sterile diluent (MERCK). The doses of VARIVAX were exposed to temperature range between 6° Fahrenheit (F) to 14°F during a time frame of 1 hour 20 minutes. There were no previous temperature excursions. Digital data logger was involved. No adverse effects were reported. Product Quality Complaint (PQC) was not involved. This is one of the several reports received from the same source. Sender's Comments: US-009507513-1709USA008861: US-009507513-1710USA013424: US-009507513-1710USA013470: US-009507513-1710USA013465: US-009507513-1710USA013440: US-009507513-1710USA013468: US-009507513-1710USA013442: US-009507513-1710USA013445: US-009507513-1710USA013460: US-009507513-1710USA013463: US-009507513-1710USA013464: US-009507513-1710USA013438: US-009507513-1710USA013439: US-009507513-1710USA013450: US-009507513-1710USA013430: US-009507513-1710USA013469: US-009507513-1710USA013467: US-009507513-1710USA013435: US-009507513-1710USA013434: US-009507513-1710USA013432: US-009507513-1710USA013428: US-009507513-1710USA013437: US-009507513-1710USA013441: US-009507513-1710USA013443: US-009507513-1710USA013444: US-009507513-1710USA013446: US-009507513-1710USA013447: US-009507513-1710USA013448: US-009507513-1710USA013436: US-009507513-1710USA013449: US-009507513-1710USA013451: US-009507513-1710USA013452: US-009507513-1710USA013454: US-009507513-1710USA013455: US-009507513-1710USA013456: US-009507513-1710USA013457: US-009507513-1710USA013458: US-009507513-1710USA013459: US-009507513-1710USA013461: US-009507513-1710USA013462: US-009507513-1710USA013466: US-009507513-1710USA013427: US-009507513-1710USA013471: US-009507513-1710USA013472: US-009507513-1710USA013473: US-009507513-1710USA013474: US-009507513-1710USA013475: US-009507513-1710USA013476: US-009507513-1710USA013425: US-009507513-1710USA013433: US-009507513-1710USA013423: US-009507513-1710USA013040: US-009507513-1710USA013426: US-009507513-1710USA013429: US-009507513-1710USA013431: US-009507513-1709USA008666: Original Case: 1709USA008666: US-009507513-1710USA014650: Original Case: 1710USA014649: US-009507513-1710USA014649: Original Case: 1710USA014649.
This spontaneous report as received from a physician via a company representative refers to a 11 year old female patient. On an unknown date the patient was vaccinated with GARDASIL (dose one, dose, units, route of administration, anatomical location, lot number were not reported). On an unknown date, 24 hours after vaccination, the patient experienced syncope while in the shower. The outcome of th syncope and relatedness between reported adverse event and GARDASIL was not reported. Additional information has been requested.
Taste and smell have been affected. Specific tastes and smells have become very unappetizing (I.e. Coffee, onions, chive, garlic). Any tastes or smells that are ?bad? now that previously were fine all taste/smell the same there is no differentiation of taste/smell.
received Pfizer dose 1 on 2/27/21 in R deltoid. Approx 2 days later, began having R elbow and forearm cellulitis w/olecranon bursitis.  Hospitalized and underwent I&D of R olecranon. Receiving treatment with antibiotic therapy.
29Jan98 Pt recv 1 dose vax. 31Jan98 Pt exp short apnea episode w/fever 103.Pt presented to ER. 01Feb98 Pt fever had "somewhat subsided", but nauseated & vomited.
Initial report received from a healthcare professional on 10 October 2012. A 34-year-old female patient whose medical history and concomitant medications were not reported; had received first intradermal (ID) dose of FLUZONE ID (lot number UT4474AA) in right deltoid on 08 October 2012. On 08 October 2012 in the evening of vaccination, the patient developed area of approximately 4 inches of induration around injection site, red and swollen states area continues at present. Details of corrective treatments were not reported. Laboratory investigation was reported as none. The patient's outcome was not recovered. Documents held by sender: None.
This spontaneous report was received from an office manager and refers to an unspecified amount of patients of unknown demographics. The patients' pertinent medical histories and drug reactions or allergies were not reported. From 01-JAN-2017 to 25-SEP-2017, the patients received an improperly stored doses ZOSTAVAX (lot # M039452 with expiration date at 19-DEC-2017, for prophylaxis; dose, route of administration and anatomical location were not reported), reconstituted with properly stored sterile diluent (dose, lot # and expiration date were not reported). There were previous temperature excursions (unknown by reporter). The reporter did not know the ranges of temperature excursions and their time frames. Data logger was not used to track the temperature. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA012746: US-009507513-1709USA012745: US-009507513-1709USA012635: US-009507513-1709USA012744.
COVID vaccinated 1/28/2021 & 2/28/2021. Hospitalized (ICU) with COVID + 4/3/22. Patient is pregnant 28w3d.
Fever, fatigue, sore heavy arm, headache (more left sided than right), neck pain, nausea
Left hand feels sleepy; This is a spontaneous report from a contactable  health care professional nurse, the patient.  A 29-years-old non-pregnant female patient (nurse) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE); Lot Number: EK5730), intramuscular in the left arm on 30Dec2020 at 14:00 as a single dose, for COVID-19 vaccination. The patient had no known medical history or allergies. Concomitant medication included amoxicillin (AMOXICILLIN).  No other vaccines were given within 4 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. On 30Dec2020 at 16:45, the patient experienced left hand feels sleepy. No Treatment was given for the event. The clinical outcome of left hand feels sleepy was not recovered.
12/5/2011 C/O swelling, itching, redness (L) upper arm since immunization 11/28/2011. Fever - improving.
Unexpected Therapeutic Benefit; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (Unexpected Therapeutic Benefit) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     The patient's past medical history included Eye floaters (Patient stated that over a year she is suffering with folaters in her eyes specially In her left eye and have been crippling. Tow doctors told her nothing that can be done. she used eye drops for the same. she got relief from this after the 2nd dose administration.).   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (Unexpected Therapeutic Benefit). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (Unexpected Therapeutic Benefit) had resolved.            Patient stated that - after the administration of 2nd dose of moderna she got relief from floaters and also she stopped using drops for that. unfortunately it didn't last, but improves her vision for several days, vaccine helped her tremendously. she wanted moderna people to look into eye drops or something better.
I started to feel fatigued around 10:30/11;00 am the morning after my J&J Covid vaccine. By lunchtime, I had chills, fever, nausea, aches and slept the better part of the next 19+ hours. Day 2 after my injection, I woke up with a horrible headache. I am still weak but improving each hour.
This spontaneous report as received from a medical assistant refers to multiple unspecified patients of unknown age and unknown gender. On an unknown date, the multiple unspecified patients were vaccinated with improperly stored M-M-R II (dose, frequency and route were not reported). No adverse effects were reported. This is one of the several reports from the same reporter. Additional information has been requested.
pt had developed a rash, suspect cellulitis.  action taken: cephalexin 500 mg 1 capsule bid for 5 days
On 9/13/03, 4 x 11cm area of erythema, 7 x 9cm area induration, 4 x 6cm central clearing area with tiny papules noted left lateral thigh per Dr. C/o bilateral hip discomfort, fever (T 99.0), malaise, nausea, vomiting.
poor response to immunization; This literature marketed report has been received from the authors of a published article titled as stated below and refers to a 23 year old male patient. The patient's concurrent conditions included autoimmune hemolytic anemia (AIHA), Non-Hodgkin Lymphoma and common variable immunodeficiency (CVID). Medical history was not reported.  On an unknown date, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (manufacturer unknown) (lot#, expiration date, dose, route of administration and anatomical location were not reported) and only responded to 4 out of 11 serotypes unique to unconjugated ones, demonstrating poor response to immunization.  The outcome of the event was unknown. The authors considered the event to be related to pneumococcal vaccine, polyvalent (23-valent) (manufacturer unknown).  Literature report. A copy of the published article is attached as further documentation of the patient's experience.
Transient swollen throat leading to cough. Current status: ok, wanted note did not see MD.
My ears felt "slightly stuffed" similar to the change in elevation after my first shot.  First the left side then the right side but it cleared up in about three hours.  This was no big deal but a friend of mine that is retired from the CDC said I should report it.   I get my second shot on March 15th,
Intense pain in right shoulder capsule/deltoid for 3 days. I could not raise my arm it was so painful. Almost 3 weeks out and I still have lingering pain in my left shoulder I never had until the shot. I have not received any treatment as I keep hoping it will just go away. If I have the same reaction when I go for the second shot I will go to my doctor.
03/30/2021 Chest tightness a few days after my last shot, no pain just tight. called my doctor, went to hospital, they ended up putting in 3 heart stints. doing ok now so far.
slight rash; This is a spontaneous report from a contactable consumer or other non-HCP. An 84-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported) via an unspecified route of administration (at the age of 84-years-old) on 06Feb2021 as first dose, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date the patient experienced slight rash. The patient received her second shot of Pfizer last Saturday, 27Feb2021 and before that she received her first shot 06Feb2021. The reason of her calling is she happened to read only today the literature they gave her. And after the first shot, she did experience a slight rash. She went to her doctor who did not seem concerned about it. she got her second shot, she still has some of that a little bit more and she was just reading that you should report a rash. It is blistered slightly, and it is a little itchy, but it is not overwhelming that she thought she should pass it and tell. And she wanted to know if an Epsom salt bath okay to take. she would like to take an Epsom salt bath. It is not medication. It is a batch for joints or skin to soothe it. The outcome of the event was unknown.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Left deltoid red and painful, tender Tx: Duricef 250mg twice/day x 7 days.
seizures - his body goes limp, he stops breathing, begins to pass out, and then after finally starting to breathe again he falls asleep - event recurrs almost daily, with several events sometimes occuring within 24 hours - seizures have continued through today and are ongoing
I really don't know if this is related that's what I want to find out.  I have developed tinnitus about 4 months after last covid vaccine.  I had no symptoms before vaccine and I went to Dr   on August 26, 2021 who is an ENT doctor and had tests.  I have no hearing lost and nothing that should be causing the tinnitus.  I read that some are experiencing tinnitus but soon after vaccination but I know with so little research this could be related.
PATIENT STATES THAT IN THE EVENING HE STARTED TO EXPERIENCE SHORTNESS OF BREATH. HE TRIED TO GET UP FROM A SEATED POSITION AND HAD WEAKNESS IN HIS LEG ALONG WITH A LOT OF PAIN AND COULD BARELY WALK. HE HAD TO HAVE HELP GETTING IN THE CAR. HE SAID HE EXPERIENCED EXTREME LEG PAIN, BACK PAIN AND NECK PAIN.
Noticed a diffuse rash/bruise below deltoid and runny to bicep. No inflame at injection site. No itchy/burning. Appeared approximately 24 hrs after injections. Pt. told to f/u w/MD. (R) rash grew and MD consultation called into office. No other symptoms reported.
Body aches and chills 10 hours after second vaccine.  Lasted 12 hours.
Patient reported leaving pharmacy and having a red rash breakout from shoulder joint to near the elbow. Described rash as red/swollen. Patient says rash has become larger/more red on 10/25/2017.
Nausea, fever of 100.7, teeth ache, headache, backache, pain at injection site
Urticaria 24 hours after immunization. Temperature of 101.5 36 hours after immunization.
My lymph node in my neck/face on the left is swollen like a baseball; I have put a warm/hot face cloth and heating pad to reduce the pain and swelling; This spontaneous case was reported by an other health care professional and describes the occurrence of LYMPHADENOPATHY (My lymph node in my neck/face on the left is swollen like a baseball) and LYMPH NODE PAIN (I have put a warm/hot face cloth and heating pad to reduce the pain and swelling) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Dec-2021, the patient experienced LYMPHADENOPATHY (My lymph node in my neck/face on the left is swollen like a baseball) and LYMPH NODE PAIN (I have put a warm/hot face cloth and heating pad to reduce the pain and swelling). At the time of the report, LYMPHADENOPATHY (My lymph node in my neck/face on the left is swollen like a baseball) and LYMPH NODE PAIN (I have put a warm/hot face cloth and heating pad to reduce the pain and swelling) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant Medications were provided by the reporter No Treatment Information were provided by the reporter   This case was linked to MOD-2021-288740 (Patient Link).
feeling cold; shivering; fever; achy; tired; headache; This case was reported by a consumer via call center representative and described the occurrence of feeling cold in a 58-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 24th June 2019, the patient received Shingrix (intramuscular). On 25th June 2019, 1 days after receiving Shingrix, the patient experienced feeling cold, shivering, fever, pain, tiredness and headache. The patient was treated with paracetamol (Tylenol). On an unknown date, the outcome of the feeling cold, shivering, pain, tiredness and headache were not recovered/not resolved and the outcome of the fever was recovering/resolving.   It was unknown if the reporter considered the feeling cold, shivering, fever, pain, tiredness and headache to be related to Shingrix.  Additional details were provided as follows: The patient received dose of Shingrix in the right deltoid. After vaccination with Shingrix, on 25th June 2019, about 3 AM, the patient woke up feeling cold and shivering. The patient went back to slept and when woke up in the morning, the patient had fever and headache and felt achy and tired. Tylenol brought the fever down. The reporter consented to follow up. As per source document, the outcome of the events were recovering, but as per case narrative the outcome of the events were not recovered.
This is a spontaneous report from a contactable consumer or other non-healthcare professional (patient) via medical information team. This is report 2 of 3. A female patient of an unspecified age received first dose of BNT162B2 (Pfizer-BioNTech COVID-19 Vaccine, Solution for injection, Lot Number: ENO179) via an unspecified route of administration, administered in left arm on 07Jun2021 as 1st single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On 08Jun2021, the patient experienced sore left arm and headache. On an unspecified date in June 2021, the patient experienced nausea but it only lasted 24 hours. The patient informed that she experienced a really bad headache, soreness in her arm & nausea for a short period and she was fine already. The patient took Advil as treatment on 08Jun2021 for arms were sore. The outcome of the events was resolved on an unspecified date in June 2021. No follow-up attempts needed. No further information is expected.
This spontaneous report as received from a medical assistant refers to a female patient of unknown age. On an unknown date the patient was vaccinated with GARDASIL (lot# and expiration date unspecified) (dose, route and anatomical location unspecified). The medical assistant reported that years ago (unknown dates) the patient was administered the second dose of GARDASIL 1 year after the first dose of GARDASIL. No adverse effects reported. At the time of report the action taken with GARDASIL was unknown. Additional information has been requested.
4/6-irregular pulse, lightheadedness, fatigue. 4/7 PVC's per EKG, increase B/P. 4/11 24 hour halter monitor (continued symptoms). 4/16 continued symptoms also pedal and LL edema palpitions feeling of impending to hospital ER. Reamins symptomatic with PVC. Meds: ASA, Lopressor.